SCHEMBL3464975

SCHEMBL3464975

O=S(=O)(Cl)CCOc1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
DRD4 P21917 4/20 0.43
DRD2 P14416 3/20 0.43
DRD3 P35462 3/20 0.43
KCNH2 Q12809 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
GPR84 Q9NQS5 2/20 0.42
ALDH3A1 P30838 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10364192 0.82 MEN1 (0.47) MEN1KMT2ACA1CA2CA9
SCHEMBL3459447 0.82 KMT2A (0.47) MEN1KMT2ACA1CA2CA9
SCHEMBL25280430 0.82 DRD2 (0.45) MEN1KMT2ACA1CA2CA9
SCHEMBL749431 0.82 KCNA3 (0.54) DRD4DRD2DRD3
SCHEMBL9326275 0.81 MMP1 (0.51) MEN1KMT2ACA1CA2CA9
SCHEMBL1345118 0.78 MAOB (0.57) DRD4DRD2DRD3KCNH2ALDH3A1
SCHEMBL9770319 0.75 DRD4 (0.59) DRD4DRD2DRD3KCNH2ALDH3A1
SCHEMBL9770302 0.75 ALDH3A1 (0.62) DRD4DRD2DRD3KCNH2ALDH3A1
SCHEMBL1777301 0.74 DRD4 (0.48) DRD4DRD2DRD3KCNH2L3MBTL1
SCHEMBL30514014 0.73 HRH3 (0.61) DRD4DRD2DRD3KCNH2ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102036560-A Substituted pyridin-4-ylmethyl sulfonamides BASF SE 2011-04-27 CN disclosed
US-20110065578-A1 Substituted Pyridin-4-ylmethyl Sulfonamides BASF SE (DE) 2011-03-17 US disclosed
WO-2009141290-A9 SUBSTITUTED PYRIDIN-4-YLMETHYL SULFONAMIDES BASF SE (DE) 2010-11-25 WO disclosed
WO-2009141290-A2 SUBSTITUTED PYRIDIN-4-YLMETHYL SULFONAMIDES BASF SE (DE) 2009-11-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065578-A1 Substituted Pyridin-4-ylmethyl Sulfonamides NANS, PNPO, NQO2 MEN1 3162/4885KMT2A 1082/4885CA1 2058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.